Supplement

The Impact of Fixed-dose Combinations on Blood Pressure Control, Persistence, and Comorbid Disease

Published Online: September 15, 2006
Log in to access PDF
Issue: Express Report - New Directions and Options for the Management of Hypertension
SUPPLEMENT CONTENT
Introduction
New Direct Renin Inhibitor as Monotherapy or in Combination with Hydrochlorothiazide Controls Blood Pressure
Valsartan Reduces Inflammatory Marker Associated with Hypertensive and Comorbid Risk; Effect Neutralized by Thiazide Diuretic
The Impact of Fixed-dose Combinations on Blood Pressure Control, Persistence, and Comorbid Disease
Ability to Control Blood Pressure and Choice of Antihypertensive Impact Development and Course of Comorbid Disease
Initial Drug Choice and Economics Affect Healthcare Utilization and Persistence
Click for Full Issue
More on AJMC.COM
No Result Found
About Us | Contact Us | Advertise | Terms & Conditions | Press Room | Copyright HCPLive 2006-2013 | Intellisphere, LLC. All Rights Reserved.
Partner Websites: Pharmacy Times | Targeted Therapies | PainLive | HCPLive | ONCLive